$PFE performed badly since 2019.  Is a large pharmaceutical with excellent dividend yield.  To be expensive, shares need to be over $54.  IS NOT JUST A COVID-19 STOCK. In the coming months shareholders will get shares in Viatris. Will return 6% per year over next 6 years. PE 11.